5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 5.33▲ | 5.30▲ | 5.24▲ | 5.23▼ | 4.83▲ |
MA10 | 5.25▲ | 5.28▲ | 5.26▲ | 5.03▲ | 4.81▲ |
MA20 | 5.26▲ | 5.13▲ | 5.09▲ | 4.99▲ | N/A |
MA50 | 4.99▲ | 4.94▲ | 4.92▲ | 5.07▲ | N/A |
MA100 | 5.03▲ | 5.06▲ | 4.89▲ | N/A | N/A |
MA200 | 5.04▲ | 4.86▲ | 5.25▲ | N/A | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.004▼ | 0.015▲ | 0.016▲ | 0.058▲ | N/A |
RSI | 57.945▲ | 58.249▲ | 58.895▲ | 51.966▲ | 49.056▼ |
STOCH | 70.989 | 50.758 | 35.985 | 64.059 | N/A |
WILL %R | -25.000 | -25.000 | -25.000 | -42.564 | -65.653 |
CCI | 47.415 | 41.860 | 58.172 | 61.692 | -30.341 |
Wednesday, August 13, 2025 11:42 AM
CALABASAS, CA AND ABU DHABI, UAE / ACCESS Newswire / August 11, 2025 / NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI), a multi-Phase 2 clinical-stage biotechnology company pioneering therapies for ...
|
Monday, August 04, 2025 06:11 AM
NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a multi-phase 2 clinical-stage biotechnology company advancing transformative treatments for brain and central nervous system cancers, was featured on ...
|
Wednesday, July 30, 2025 12:35 PM
NEW YORK CITY, NEW YORK / ACCESS Newswire / July 30, 2025 / New to The Street, the nation's premier financial media platform for emerging public companies, proudly announces a major media ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 4.94 | 5.45 | 4.94 | 5.12 | 66,153 |
14/08/25 | 5.37 | 5.37 | 5.06 | 5.19 | 15,967 |
13/08/25 | 5.21 | 5.70 | 5.0201 | 5.32 | 116,668 |
12/08/25 | 5.29 | 5.59 | 4.9501 | 5.43 | 77,351 |
11/08/25 | 4.99 | 5.37 | 4.66 | 5.11 | 114,588 |
08/08/25 | 4.77 | 4.82 | 4.60 | 4.79 | 28,429 |
07/08/25 | 4.80 | 4.92 | 4.60 | 4.80 | 38,500 |
06/08/25 | 4.79 | 4.95 | 4.50 | 4.95 | 37,014 |
05/08/25 | 4.73 | 4.87 | 4.63 | 4.715 | 34,604 |
04/08/25 | 4.88 | 5.0177 | 4.64 | 4.90 | 71,703 |
|
|
||||
|
|
||||
|
|